Skip to main content
Afshin Ameri, MD, Pediatric Hematology & Oncology, Augusta, GA, WellStar MCG Health, affiliated with Medical College of Georgia

AfshinAmeriMD

Pediatric Hematology & Oncology Augusta, GA

Associate Professor, Pediatrics, Medical College of Georgia at Georgia Health Sciences University

Dr. Ameri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ameri's full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Pediatric Hematology/Oncology, 1995 - 1998
  • University of Chicago
    University of ChicagoResidency, Pediatrics, 1993 - 1995
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Pediatrics, 1992 - 1993
  • Philipps University of Marburg Faculty of Medicine
    Philipps University of Marburg Faculty of MedicineClass of 1986

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2003 - 2025
  • OH State Medical License
    OH State Medical License 2003 - 2011
  • MI State Medical License
    MI State Medical License 1996 - 2006
  • KY State Medical License
    KY State Medical License 2000 - 2004
  • IL State Medical License
    IL State Medical License 1993 - 1995
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies (Inhibitors) Directed Against Therapeuti...
    Afshin Ameri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations